You are here: Industry Insights > aspirin

News List

Janssen Submits sNDA for Expanded Use of XARELTO americanpharmaceuticalreview
October 30, 2020
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with ...
Aspirin could protect patients from severe COVID-19 complications europeanpharmaceuticalreview
October 26, 2020
A study has shown that aspirin use was associated with a 47 percent decrease in the risk of dying in the hospital from COVID-19.
The FDA requires changes to NSAID labelling europeanpharmaceuticalreview
October 21, 2020
The FDA is requiring that the prescribing information for nonsteroidal anti-inflammatory drugs (NSAIDs) include warnings about potential foetal kidney problems if taken by women over 20 weeks pregnant.
Brilinta significantly reduced rate of composite of stroke and death in THALES trial pharmaceutical-business-review
July 21, 2020
Detailed results from the positive Phase III THALES trial showed AstraZeneca’s Brilinta (ticagrelor) 90mg used twice daily and taken with daily aspirin for 30 days, reduced the rate of the primary composite endpoint of stroke and death by 17% (HR 0.83 ...
AZ unveils detailed data from THALES trial pharmatimes
July 16, 2020
AstraZeneca has now shared detailed results from the Phase III THALES, showing that a combination of twice daily Brilinta (ticagrelor) and daily aspirin reduced the rate of stroke and death (the composite primary endpoint) by 17% after 30 days ...
US priority review for AZ' Brilinta/aspirin combination pharmatimes
July 14, 2020
The US Food and Drug Administration has agreed to a speedy review of AstraZeneca's Brilinta (ticagrelor) for the reduction of subsequent stroke in patients who have experienced an acute ischaemic stroke or transient ischaemic attack (TIA).
Regular dose of aspirin can lower risk of inherited bowel cancer: Study expresspharma
June 15, 2020
The research, carried out by Universities of Newcastle and Leeds, and funded by Cancer Research UK, NIHR, Bayer Pharma AG and the Barbour Foundation ...
Low-dose aspirin linked to reduced liver cancer risk worldpharmanews
March 13, 2020
Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes.
Aspirin appears to curb colorectal cancer recurrence and tumor growth worldpharmanews
January 09, 2020
The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and ...
Evidence Supports Use of High-Dose Aspirin for Migraine drugs
December 26, 2019
Evidence supports the use of high-dose aspirin for treating acute migraine and low-dose aspirin for prevention of recurrent attacks ...

Previous page 1 2 3 4 5 6 Next page